New patent for Janssen Biotech drug ERLEADABy DrugPatentWatch – Make Better Decisions / April 30, 2024 Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are ten patents…Source